Drawing for EMODIAL

USPTO serial 79335156

EMODIAL

Reviewed by CopyMark Law Group

Reg. 7171754Status 700Registered
Filing date
Status date
Registration date
Sep 26, 2023
Examiner
HUTCHISON, DAVID A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EMODIAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard M. Goldberg

Richard M. Goldberg Goldberg Patent Law Office25 East Salem StreetSuite 419Hackensack, NJ 07601

Goods and services

ClassDescriptionStatusFirst use
005Alginates for pharmaceutical purposes; bandages for dressings; adhesive bandages for medical purposes; surgical bandages; plasters for medical purposes; cotton for medical purposes; disinfectants for medical purposes; self-adhesive dressings; gauze for dressings; lint for medical purposes; materials for wound dressings and for catheters protection, namely non-woven and waterproof materials of non-woven fabric, polyurethane, plastic; surgical and medical dressings; medical dressings impregnated with antibacterial preparations; medication products for catheters protection, namely non-woven and waterproof materials of non-woven fabric, polyurethane, plastic; medication products for catheters, namely, medication based on antibacterial substances; fistula dressing products, namely, multilayer non-stick absorbent dressings; tampons for medical purposes; medical dressings; sticking plasters for medical use; medical and surgical plasters; medicated compressesACTIVE—
010Hemodialysis apparatus; medical apparatus and instruments, namely prostheses for arteriovenous shunt fistulas; dialyzers; catheters; medical catheters; central venous catheters; peritoneal catheters; syringes for medical purposes; compression bandages; belts for medical purposes; gloves for medical purposes; hemostats; dressing forceps; hypodermic syringes; disposable syringes; surgical and medical equipment and instruments of the disposable type, namely, tampons, plasters and hemostatic bandages; products for the protection and fixing of catheters, namely, products in the nature of plasters, pads, pockets to avoid dislodgement and contamination of the catheter; surgical apparatus and instruments for medical useACTIVE—
042Medical research; design and development of medical technology; scientific and medical research and development; medical research laboratory services; design and development of computer hardware and software for use in the field of medicine; design and development of medical diagnostic apparatus; design and development of computer software for use with medical technology; design of diagnostic apparatus; development of diagnostic apparatus; technical design services in the field of health equipment and systems; medical equipment design services; research services in the field of medical equipment; medical device design and development services; research and development services in the field of medical devices; research in the field of artificial intelligence; providing temporary use of non-downloadable computer programs for artificial intelligence on data networks for use in the medical field; platforms as a service (PAAS) featuring artificial intelligence software for use in the medical fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 22, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 28, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 28, 2023FIMPFINAL DISPOSITION PROCESSED—
Dec 26, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 26, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 26, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 9, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 9, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jun 21, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 21, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 21, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 7, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 7, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 7, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 7, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 5, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 14, 2023RFNPREFUSAL PROCESSED BY IB—
Jan 20, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 19, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 15, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2022DOCKASSIGNED TO EXAMINER—
Apr 5, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 31, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Mar 3, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance